BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16294014)

  • 1. Ras-Raf signaling needs prohibitin.
    Rajalingam K; Rudel T
    Cell Cycle; 2005 Nov; 4(11):1503-5. PubMed ID: 16294014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
    Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
    Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
    Chang F; Steelman LS; Shelton JG; Lee JT; Navolanic PM; Blalock WL; Franklin R; McCubrey JA
    Int J Oncol; 2003 Mar; 22(3):469-80. PubMed ID: 12579299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway.
    Tang CH; Tsai CC
    Biochem Pharmacol; 2012 Feb; 83(3):335-44. PubMed ID: 22138288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
    Luan Z; He Y; Alattar M; Chen Z; He F
    Mol Cancer; 2014 Feb; 13():38. PubMed ID: 24568222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane.
    Chiu CF; Ho MY; Peng JM; Hung SW; Lee WH; Liang CM; Liang SM
    Oncogene; 2013 Feb; 32(6):777-87. PubMed ID: 22410782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KSR is a scaffold required for activation of the ERK/MAPK module.
    Roy F; Laberge G; Douziech M; Ferland-McCollough D; Therrien M
    Genes Dev; 2002 Feb; 16(4):427-38. PubMed ID: 11850406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signaling.
    Zhu B; Zhai J; Zhu H; Kyprianou N
    Prostate; 2010 Jan; 70(1):17-26. PubMed ID: 19725029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Wong EW; Chang F; Lehmann B; Terrian DM; Milella M; Tafuri A; Stivala F; Libra M; Basecke J; Evangelisti C; Martelli AM; Franklin RA
    Biochim Biophys Acta; 2007 Aug; 1773(8):1263-84. PubMed ID: 17126425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
    Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
    Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
    Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
    Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors.
    Weinstein-Oppenheimer CR; Blalock WL; Steelman LS; Chang F; McCubrey JA
    Pharmacol Ther; 2000 Dec; 88(3):229-79. PubMed ID: 11337027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-α expression.
    Robbs BK; Lucena PI; Viola JP
    Biochim Biophys Acta; 2013 Aug; 1833(8):2016-28. PubMed ID: 23583303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival.
    Ninomiya Y; Kato K; Takahashi A; Ueoka Y; Kamikihara T; Arima T; Matsuda T; Kato H; Nishida J; Wake N
    Cancer Res; 2004 Apr; 64(8):2759-65. PubMed ID: 15087391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.